Market Overview:
The global surgical heart valve management products market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in surgical heart valve management products, and rising demand for minimally invasive procedures. Based on type, the global surgical heart valve management products market is segmented into percutaneous balloon valvuloplasty, heart valve surgery, heart valve repair, and heart valve replacement. The percutaneous balloon valvuloplasty segment is expected to grow at the highest CAGR during the forecast period owing to its growing popularity as a minimally invasive procedure for treating congenital and acquired cardiac valves diseases. Based on application, the global surgical heart valve management products market is segmented into hospitals, ambulatory surgical centers (ASCs), and cardiac catheterization laboratories (CCLs). The hospitals segment accounted for majority of the share in 2017 and is projected to maintain its dominance during the forecast period. This can be attributed to increasing number of hospital admissions due to rising incidence of cardiovascular diseases across regions worldwide.
Product Definition:
Surgical heart valve management products are devices that are inserted into the body to help open and keep open a heart valve. These products may be used to treat a variety of conditions, including narrowing of the valve (stenosis), leakage of the valve (regurgitation), or blockage of the blood flow through the valve (obstruction).
Percutaneous Balloon Valvuloplasty :
Percutaneous balloon valvuloplasty (PBBV) is a minimally invasive procedure used to treat degenerative mitral valve disease. The Percutaneous Valve Replacement (PVR) market was valued at USD 3,074 million in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Heart Valve Surgery :
The heart valve surgery is used in surgical heart valve management products market for the treatment of congenital heart diseases and other disorders. The surgical procedures are performed to replace or repair damaged cardiac valves, which may result from a variety of conditions such as infections, genetic mutations, and others. According to the American Heart Association (AHA), about 400000 people in U.S have aortic stenosis; out of them about 30% are elderly people with more than 60 years and above.
Application Insights:
Based on application, the global surgical heart valve management products market is segmented into hospitals, ambulatory surgical centers and cardiac catheterization laboratories. The hospital segment dominated the overall market in terms of revenue in 2017 owing to factors such as a higher prevalence of cardiovascular diseases and rising geriatric population at hospitals worldwide. According to data published by WHO, around 1 billion people suffer from some form of cardiovascular disease globally which accounts for around 23% of all deaths caused by disease globally.
The cardiac catheterization laboratory is expected to be one of the fastest-growing segments over the forecast period due to increasing demand for accurate diagnosis with minimally invasive procedures that are cost-effective compared to open heart surgeries performed traditionally. Moreover, an increase in R&D activities pertaining conventional mechanical valves that can be used in smaller body parts than actual valves would help reduce surgery time and costs while improving patient outcomes during future product launches or approvals by regulatory authorities across regions.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large patient pool and favorable reimbursement policies. The U.S., which is at the forefront, accounted for over 80% of North America market share in 2017 due to high unmet needs regarding valve replacement surgeries and increasing geriatric population prone to valvular diseases. Moreover, quick adoption of technologically advanced products also contributes toward regional growth.
Asia Pacific is expected to register lucrative growth during the forecast period owing to improving healthcare infrastructure and rising awareness about surgical treatment options for heart disorders & valvular diseases such as aortic stenosis, tricuspid regurgitation, biventricular failure etc.; However; low per capita income coupled with high prevalence rate of infectious & chronic disorders may hinder its growth further (WHO 2014). Furthermore Valves Asia has observed that approximately 90% patients come from developing countries such as India or China (Gulati et al 2016).
Growth Factors:
- Increasing incidence of heart valve diseases
- Growing geriatric population
- Rising demand for minimally invasive surgeries
- Technological advancements in surgical heart valve management products
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Surgical Heart Valve Management Products Market Research Report
By Type
Percutaneous Balloon Valvuloplasty , Heart Valve Surgery , Heart Valve Repair , Heart Valve Replacement
By Application
Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratory
By Companies
Abbott Laboratories, Becton Dickinson, Medtronic, Biostable Science & Engineering, C.R. Bard, CardiaMed, Cook Medical, CorMatrix Cardiovascular, CryoLife, Edwards Lifesciences, Abbott Laboratories, Labcor, Lepu Medical, LivaNova, Medtentia, NuMed, ON-X Life Technologies, Osypka, Venus Medtech, TTK Healthcare, Wyss Institute
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
128
Number of Tables & Figures
90
Customization Available
Yes, the report can be customized as per your need.
Global Surgical Heart Valve Management Products Market Report Segments:
The global Surgical Heart Valve Management Products market is segmented on the basis of:
Types
Percutaneous Balloon Valvuloplasty , Heart Valve Surgery , Heart Valve Repair , Heart Valve Replacement
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Becton Dickinson
- Medtronic
- Biostable Science & Engineering
- C.R. Bard
- CardiaMed
- Cook Medical
- CorMatrix Cardiovascular
- CryoLife
- Edwards Lifesciences
- Abbott Laboratories
- Labcor
- Lepu Medical
- LivaNova
- Medtentia
- NuMed
- ON-X Life Technologies
- Osypka
- Venus Medtech
- TTK Healthcare
- Wyss Institute
Highlights of The Surgical Heart Valve Management Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Percutaneous Balloon Valvuloplasty
- Heart Valve Surgery
- Heart Valve Repair
- Heart Valve Replacement
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Surgical Heart Valve Management Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Surgical heart valve management products are medical devices used to help surgeons manage the health of a patient's heart valves. These products can include tools and supplies needed for surgery, as well as medications or treatments that may be prescribed to help keep the patient's heart functioning properly.
Some of the key players operating in the surgical heart valve management products market are Abbott Laboratories, Becton Dickinson, Medtronic, Biostable Science & Engineering, C.R. Bard, CardiaMed, Cook Medical, CorMatrix Cardiovascular, CryoLife, Edwards Lifesciences, Abbott Laboratories, Labcor, Lepu Medical, LivaNova, Medtentia, NuMed, ON-X Life Technologies, Osypka, Venus Medtech, TTK Healthcare, Wyss Institute.
The surgical heart valve management products market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Surgical Heart Valve Management Products Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Surgical Heart Valve Management Products Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Surgical Heart Valve Management Products Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Surgical Heart Valve Management Products Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Surgical Heart Valve Management Products Market Size & Forecast, 2018-2028 4.5.1 Surgical Heart Valve Management Products Market Size and Y-o-Y Growth 4.5.2 Surgical Heart Valve Management Products Market Absolute $ Opportunity
Chapter 5 Global Surgical Heart Valve Management Products Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Surgical Heart Valve Management Products Market Size Forecast by Type
5.2.1 Percutaneous Balloon Valvuloplasty
5.2.2 Heart Valve Surgery
5.2.3 Heart Valve Repair
5.2.4 Heart Valve Replacement
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Surgical Heart Valve Management Products Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Surgical Heart Valve Management Products Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Cardiac Catheterization Laboratory
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Surgical Heart Valve Management Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Surgical Heart Valve Management Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Surgical Heart Valve Management Products Analysis and Forecast
9.1 Introduction
9.2 North America Surgical Heart Valve Management Products Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Surgical Heart Valve Management Products Market Size Forecast by Type
9.6.1 Percutaneous Balloon Valvuloplasty
9.6.2 Heart Valve Surgery
9.6.3 Heart Valve Repair
9.6.4 Heart Valve Replacement
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Surgical Heart Valve Management Products Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Cardiac Catheterization Laboratory
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Surgical Heart Valve Management Products Analysis and Forecast
10.1 Introduction
10.2 Europe Surgical Heart Valve Management Products Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Surgical Heart Valve Management Products Market Size Forecast by Type
10.6.1 Percutaneous Balloon Valvuloplasty
10.6.2 Heart Valve Surgery
10.6.3 Heart Valve Repair
10.6.4 Heart Valve Replacement
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Surgical Heart Valve Management Products Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Cardiac Catheterization Laboratory
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Surgical Heart Valve Management Products Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Surgical Heart Valve Management Products Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Surgical Heart Valve Management Products Market Size Forecast by Type
11.6.1 Percutaneous Balloon Valvuloplasty
11.6.2 Heart Valve Surgery
11.6.3 Heart Valve Repair
11.6.4 Heart Valve Replacement
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Surgical Heart Valve Management Products Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Cardiac Catheterization Laboratory
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Surgical Heart Valve Management Products Analysis and Forecast
12.1 Introduction
12.2 Latin America Surgical Heart Valve Management Products Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Surgical Heart Valve Management Products Market Size Forecast by Type
12.6.1 Percutaneous Balloon Valvuloplasty
12.6.2 Heart Valve Surgery
12.6.3 Heart Valve Repair
12.6.4 Heart Valve Replacement
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Surgical Heart Valve Management Products Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Cardiac Catheterization Laboratory
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Surgical Heart Valve Management Products Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Surgical Heart Valve Management Products Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Surgical Heart Valve Management Products Market Size Forecast by Type
13.6.1 Percutaneous Balloon Valvuloplasty
13.6.2 Heart Valve Surgery
13.6.3 Heart Valve Repair
13.6.4 Heart Valve Replacement
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Surgical Heart Valve Management Products Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Cardiac Catheterization Laboratory
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Surgical Heart Valve Management Products Market: Competitive Dashboard
14.2 Global Surgical Heart Valve Management Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Becton Dickinson
14.3.3 Medtronic
14.3.4 Biostable Science & Engineering
14.3.5 C.R. Bard
14.3.6 CardiaMed
14.3.7 Cook Medical
14.3.8 CorMatrix Cardiovascular
14.3.9 CryoLife
14.3.10 Edwards Lifesciences
14.3.11 Abbott Laboratories
14.3.12 Labcor
14.3.13 Lepu Medical
14.3.14 LivaNova
14.3.15 Medtentia
14.3.16 NuMed
14.3.17 ON-X Life Technologies
14.3.18 Osypka
14.3.19 Venus Medtech
14.3.20 TTK Healthcare
14.3.21 Wyss Institute